subsidiaries financial statement for the fiscal year 2014, ended as of December 31, 2014 (Revised Version) which details are as following; Result 2014 (Revised Version) 2013 Increase (Decrease) Million Baht
(Revised Version) Increase (Decrease) Million Baht Million Baht Million Baht Percentage Total Revenues 851.16 1,017.71 (166.55) (16.37) Cost of Goods Sold and Service (854.84) (1,006.56) (151.72) (15.07
) Increase (Decrease) Million Baht Million Baht Million Baht Percentage Total Revenues 904.62 1,082.18 (177.56) (16.41) Cost of Goods Sold and Service 919.37 1,123.45 (204.08) (18.17) Sell and Administration
and allocating not more than 149,975,200 new ordinary shares with a par value of Baht 1 per share by the General Mandate. The Company registered the decrease in its registered capital with the Ministry
decreased of Baht 2.55 million resulted from a decrease in recognition of share loss from associated company of Baht 2.55 million. Therefore, The Company would like to report the reviewed/audited operating
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
revenue decreased by 9.32% year-on-year. Sales and service income decreased by 10.60%, with 5.93% increase in automotive parts businesses but 46.72% decrease in dealership businesses. The automotive part
on new electric vehicles which resulted in a decrease in automobile output. 2) Car Dealerships Business; Higher sales in dealership business both in Thailand and Malaysia. In Thailand, sales growth was
1 25 May 2020 Subject: Notification on Resolution of the Board of Directors’ Meeting No. 5/2020, Change of Directors and Directors’ Power, Entering into Connected Transaction, Entering into
Transaction constitute a disposition of assets of subsidiaries of UWC which considered as a disposition of assets of CEN according to the Notification of the Capital Market Supervisory Board no. ThorChor. 20